Newly Established Telemedicine Company Equity Stake For Sale in Santiago de Querétaro, Mexico
| Established | 0-1 year(s) |
| Employees | 5 - 10 |
| Legal Entity | Limited Liability Company (LLC) |
| Reported Sales | USD 30 thousand |
| Run Rate Sales | USD 44 thousand |
| EBITDA Margin | Operating at loss |
| Industries | Telemedicine |
| Locations | Santiago de Querétaro |
| Local Time | 9:26 PM America / Mexico City |
| Listed By | Business Owner / Director |
| Status | Active |
- The primary revenue driver comes from corporate memberships, which constitute approximately 70% of total sales. These memberships provide businesses with a cost-effective solution to improve employee wellness and reduce absenteeism.
- Offer unlimited telemedicine consultations in 6 specialties: general medicine, pediatrics, gynecology, internal medicine, general psychology, and nutrition, all accessible via app or web.
- Boasts a high retention rate of over 90%, enhancing customer loyalty and recurring revenue in its corporate sector, with 1,270+ active users across 427 memberships.
- Family memberships represent a high-margin growth opportunity, allowing households of up to 4 members to access the same comprehensive set of medical services, appealing to middle-class families seeking affordable healthcare.
- The business also generates additional revenue from ancillary services such as integrated pharmacy delivery, laboratory testing, executive check-ups, and in-clinic visits, offered at exclusive discounts for members.
- With early revenue projections surpassed by 66%, we already achieved $730,000 MXN in revenue this year (10 months), signifying strong demand for both corporate and family telemedicine solutions.
- The company’s customer satisfaction is evident with an impressive NPS (Net Promoter Score) of +85 and a 4.1-star rating, reflecting a high level of service quality and positive user experience.
- Offering: Scalable unlimited telemedicine memberships in packs of 1, 4, or 10 users.
- Covering 6 specialties: general medicine, pediatrics, gynecology, internal medicine, general psychology, and nutrition.
- Usage: Businesses deploy for employee wellness programs, enabling 24/7 virtual consultations via app or web, reducing absenteeism, enhancing retention, and providing seamless access without disrupting workflows. - High retention: 90%+ renewal rate.
2. Family memberships (high-margin growth opportunity)
- Offering: Unlimited telemedicine access for households (up to 4 members) across the same 6 specialties, positioned as a premium retail telemedicine solution for non-corporate segments.
- Target customers: Middle-class families and individuals seeking affordable, proactive healthcare alternatives.
3. Ancillary services (upsell & ecosystem revenue)
- Offering: Integrated pharmacy delivery, laboratory testing, executive check-ups, and in-clinic retail visits, all with exclusive member discounts (5-10%).
- Target customers: Existing corporate & family members and regional customers.
- Location: Querétaro, Mexico.
- Built-up area 121 m² (fully utilized) 1 floor (ground-level) - Capacity - 6 consultation rooms + reception/waiting/labs/pharmacy.
- Consult rooms: 6x (3.3–4.8 m²) – general medicine, pediatrics, gynae, psych, nutrition and internal medicine.
- Patient zones: Reception (21.5 m²) | waiting (10.5 m²) | restrooms (x4).
- Support: Kitchenette, storage – hybrid-ready for telemed overflow.
- Facility is on rent.
Ops synergy:
- Doctor pool: Shared core team → clinic + telemedicine (auto-scales on volume).
- Admin backbone: Parent org – end-to-end support: accounting, marketing, IT, legal, HR and daily management.
- Source: 100% bootstrapped via founders + friends & family – funded flagship clinic launch, telemedicine rollout & $730K YTD revenue without dilution.
- Outstanding debts: $0 MXN – zero leverage | 100% equity-funded (no banks, clean balance sheet).
Moving now to seek support from bigger investments:
- R1 opportunity: 70M MXN for 40% equity (staggered 25 mos. )
- Working with a premium-based investment after this round, to secure benefits for initial risk takers.